Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The difference between groups is presented and data given as means ± standard deviationChange from baseline to 12 monthsEnd pointFamily Meals on PrescriptionControl groupP valueHbA1C: mmol/mol (n)0.60 ± 1.68 (35)1.79 ± 1.82 (24)0.01*Fasting plasma glucose: mmol/L (n) − 0.02 ± 0.39 (37) − 0.14 ± 0.47 (22)0.30Insulin: mU/L (n)1.63 ± 11.98 (35)0.45 ± 9.74 (22)0.70Cholesterol: mmol/L (n) − 0.23 ± 0.59 (36) − 0.20 ± 0.53 (24)0.81High-density lipoprotein: mmol/L (n)0.04 ± 0.19 (36)0.04 ± 0.19 (24)1.00Low-density lipoprotein: mmol/L (n) − 0.25 ± 0.48 (36) − 0.24 ± 0.44 (23)0.88Triglycerides: mmol/L (n) − 0.06 ± 0.47 (36) − 0.17 ± 0.56 (23)0.44ALAT: µkat/L (n) − 0.3 ± 0.20 (37) − 0.13 ± 0.37 (23)0.1725 OH-vitamin D: nmol/L (n) − 2.88 ± 17.86 (33) − 2.90 ± 15 (20)0.10*Significant change
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Other blinding reported · Human research reported
Reported blinded roles: participants.
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Family meals on prescription as treatment for childhood obesity: a randomized controlled trial
Source: Article title.
Eligible patients were invited to an information meeting and were informed in connection with visits at the clinic.
Source: Methods.
Due to the nature of the intervention, neither participants nor members of the obesity team were blinded to the intervention.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Family meals on prescription as treatment for childhood obesity: a randomized controlled trial
Randomised controlled trial · European Journal of Pediatrics · 2024
Original publication title
Family meals on prescription as treatment for childhood obesity: a randomized controlled trial
© The Author(s) 2024
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
The aim with the present study was to evaluate the effects and tolerability of Family Meals on Prescription, a 3-month intensive dietary intervention with a participatory approach on body mass index (BMI) and metabolic health in children living with obesity. In this prospective randomized controlled trial, children aged 5 to 15 years were included from the Pediatric Obesity outpatient Clinics in Halland, Sweden. Participants were randomly assigned to receive lifestyle treatment with or without Family Meals on Prescription (FMP) consisting of a subsidized prepacked grocery bag including recipes and provisions for five Family Meals per week for 3 months.
The primary endpoint was changed in BMIz after 3, 12 and 18 to 24 months and secondary endpoints included to assess tolerability of FMP and effects on metabolic biomarker and frequency of shared meals. Eighty-nine children (51.7% female) entered the study, 54 patients in the intervention group and 35 in the control group. There were no significant differences between the groups concerning gender, age or level of obesity at baseline. The Family Meal on Prescription intervention combined with lifestyle treatment led to a significantly greater reduction in BMIz than lifestyle treatment alone after the 3-month long intervention (− 0.17 vs + 0.01, p < 0.01); however, this difference was not sustained throughout the study period, and in fact, the control group had a greater reduction in BMIz after 18 to 24 months.
A subsidized prepacked grocery bag may be a novel, well-tolerated and effective tool in the treatment of childhood obesity. The fact that the BMIz reduction shown at the end of the intervention did not persist over time emphasized the need of long-term treatment. Registered at clinicaltrals.gov 27 Nov 2020, retrospectively registered: clinicaltrials.gov number 19002468. https://clinicaltrials.gov/study/NCT05225350
What is Known: • Swedish data shows that lifestyle treatment alone is not sufficient for many families undergoing treatment for childhood obesity. • Regular family meals and mealtime routines have been shown to be important for nutritional health and dietary patterns in children and adolescents. | |
What is New: • This intervention with a participatory approach involving prepacked family meals was well tolerated and led to a significant reduction in BMIz during the intervention. • That fact that these results were not sustained over time indicates a need to evaluate longer interventions, and that childhood obesity is a chronic and complex disease which requires long-time treatments. |
Supplementary Information
The online version contains supplementary material available at 10.1007/s00431-024-05744-8.
Authors’ abstract
The aim with the present study was to evaluate the effects and tolerability of Family Meals on Prescription, a 3-month intensive dietary intervention with a participatory approach on body mass index (BMI) and metabolic health in children living with obesity. In this prospective randomized controlled trial, children aged 5 to 15 years were included from the Pediatric Obesity outpatient Clinics in Halland, Sweden. Participants were randomly assigned to receive lifestyle treatment with or without Family Meals on Prescription (FMP) consisting of a subsidized prepacked grocery bag including recipes and provisions for five Family Meals per week for 3 months.
The primary endpoint was changed in BMIz after 3, 12 and 18 to 24 months and secondary endpoints included to assess tolerability of FMP and effects on metabolic biomarker and frequency of shared meals. Eighty-nine children (51.7% female) entered the study, 54 patients in the intervention group and 35 in the control group. There were no significant differences between the groups concerning gender, age or level of obesity at baseline. The Family Meal on Prescription intervention combined with lifestyle treatment led to a significantly greater reduction in BMIz than lifestyle treatment alone after the 3-month long intervention (− 0.17 vs + 0.01, p < 0.01); however, this difference was not sustained throughout the study period, and in fact, the control group had a greater reduction in BMIz after 18 to 24 months.
A subsidized prepacked grocery bag may be a novel, well-tolerated and effective tool in the treatment of childhood obesity. The fact that the BMIz reduction shown at the end of the intervention did not persist over time emphasized the need of long-term treatment. Registered at clinicaltrals.gov 27 Nov 2020, retrospectively registered: clinicaltrials.gov number 19002468. https://clinicaltrials.gov/study/NCT05225350
What is Known: • Swedish data shows that lifestyle treatment alone is not sufficient for many families undergoing treatment for childhood obesity. • Regular family meals and mealtime routines have been shown to be important for nutritional health and dietary patterns in children and adolescents. | |
What is New: • This intervention with a participatory approach involving prepacked family meals was well tolerated and led to a significant reduction in BMIz during the intervention. • That fact that these results were not sustained over time indicates a need to evaluate longer interventions, and that childhood obesity is a chronic and complex disease which requires long-time treatments. |
Supplementary Information
The online version contains supplementary material available at 10.1007/s00431-024-05744-8.
Publication and source details
Original title: Family meals on prescription as treatment for childhood obesity: a randomized controlled trial
Terese Torstensson; Anna Bohlin; Gerd Almqvist-Tangen; Josefine Roswall; Jenny M. Kindblom; Lovisa Sjogren
European Journal of Pediatrics · 2024
Communicated by: Gregorio Milani
Open access funding provided by University of Gothenburg.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T09:31:47.486978+00:00
DOI: 10.1007/s00431-024-05744-8 · PMC11473609